| May 18, 2014
Research labs closed by pharmaceutical giant Pfizer dot the country: Illinois. Michigan. New Jersey. New York. North Carolina.
Maryland officials don't want this state to join that list.
After Pfizer declared its desire to buy AstraZeneca — which...
| May 20, 2014
| 3:00 AM
Athletes associate STX with lacrosse, but the Baltimore-based brand began appearing last month in stores on ice hockey sticks and plans to launch a line of men's field hockey sticks in the United Kingdom.
For the 44-year-old inventor of the modern...
| Mar 12, 2014
Re "Prices of new drugs tough to take," March 10
I understand the necessity for drug companies to recoup research and development costs. But in regard to a medication that can cure hepatitis C, a spokesman for the maker of one drug that costs about $1,...
| Mar 24, 2014
| 3:00 AM
Earlier this General Assembly session, we joined together to announce a transformational economic development commission, a part of a joint economic development agenda that builds on the strategic investments Gov. Martin O'Malley and the legislature...
| Apr 9, 2014
| 7:46 AM
Lupin Pharmaceuticals, Inc. has placed its name in lights over the Inner Harbor, a mark of the Indian drug manufacturer's growing presence since the company located its U.S. headquarters in Baltimore more than a decade ago.
Lupin, which today sells...
| Apr 15, 2014
| 4:15 PM
Newport News Shipbuilding and NASA Langley Research Center in Hampton are feeling the pinch of budget uncertainty in Washington, but Sen. Tim Kaine says Congress might clear that up in the coming weeks.
The Virginia Democrat toured both facilities...
| Apr 22, 2014
| 7:33 PM
Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....
| Apr 21, 2014
| 8:41 PM
Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox.
Ackman and Valeant Pharmaceuticals International Inc. have already...
| Oct 1, 2013
| 8:33 AM
Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.
That's on top of a previous announcement that the Whitehouse Station, N.J.-based...
| Nov 23, 2013
| 7:24 PM
WASHINGTON — Despite intense pressure to hold down federal spending, the Defense Department is launching a high-priced effort to create its own production pipeline for vaccines and biodefense drugs — an initiative that defies the advice of...
| Dec 18, 2013
| 11:55 AM
Followers of Herbalife, the Los Angeles peddler of nutritional supplements, know it's actually two stories rolled into one.
One is the story of how a company with a questionable business model, overhyped products, and an almost invisible research and...